½ÃÀ庸°í¼­
»óǰÄÚµå
1360091

À¯·´ÀÇ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå ¿¹Ãø(-2030³â) - Áö¿ªº° ºÐ¼® : °ø±Þ¿ø, ÇüÅÂ, ¿ëµµº°

Europe Collagen Peptides Market Forecast to 2030 -Regional Analysis - by Source (Bovine, Porcine, Poultry, Marine, And Others), Form (Dry and Liquid), Application (Food & Beverages, Pharmaceuticals & Nutraceuticals, Personal Care, and Others)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 121 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

À¯·´ÀÇ Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀº 2023³â 2¾ï 6,084¸¸ ´Þ·¯¿¡¼­ 2030³â 3¾ï 7,961¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023³âºÎÅÍ 2030³â±îÁö CAGRÀº 5.5%·Î ÃßÁ¤µË´Ï´Ù.

³ÐÀº ÀÀ¿ë ¹üÀ§°¡ À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

Äݶó°Õ ÆéŸÀ̵å´Â °áÇÕÁ¶Á÷, ÇǺÎ, ÈûÁÙ, »À, ¿¬°ñ ¹× ±âŸ ½Åü ºÎÀ§¿¡¼­ ¹ß°ßµÇ´Â Äݶó°ÕÀÇ °¡¼öºÐÇØ¿¡ ÀÇÇØ »ý¼ºµÇ´Â ±¸Á¶ ´Ü¹éÁúÀÔ´Ï´Ù. Á¶Á÷À» ±¸Á¶ÀûÀ¸·Î ÁöÁöÇϰí Á¶Á÷ Ä¡À¯, ¸é¿ª ¹ÝÀÀ, ¼¼Æ÷ Åë½Å, ¼¼Æ÷ À̵¿°ú °°Àº ¼¼Æ÷ ±â´É¿¡ °ü¿©ÇÕ´Ï´Ù. Äݶó°ÕÀº ÀϹÝÀûÀ¸·Î ¼ÒÀÇ °áÇÕÁ¶Á÷À̳ª ÇØ¾ç ÀÚ¿ø¿¡¼­ ¾ò½À´Ï´Ù. Äݶó°ÕÀº ½ÄÀ½·á, ÀǾàǰ, °Ç°­º¸Á¶½Äǰ, ÆÛ½º³ÎÄÉ¾î µî ´Ù¾çÇÑ ÃÖÁ¾ ÀÌ¿ë »ê¾÷¿¡¼­ ´Ù¾çÇÏ°Ô È°¿ëµÇ°í ÀÖ½À´Ï´Ù. ½ÄÀ½·á »ê¾÷¿¡¼­ Äݶó°Õ ÆéŸÀ̵å´Â ¿ä±¸¸£Æ®, °úÀÚ, ¿µ¾ç¹Ù, À½·á¼ö µî ´Ù¾çÇÑ ½Äǰ¿¡ »ç¿ëµË´Ï´Ù. Äݶó°Õ ÆéŸÀ̵尡 ÇÔÀ¯µÈ À½·á´Â ü³» ´Ü¹éÁú ¼öÁØÀ» ³ôÀ̰í, ÇǺΠ°áÀ» °³¼±Çϰí, »À¿Í ±ÙÀ°ÀÇ °Ç°­À» °³¼±Çϰí, °üÀýÀ» °­È­ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Äݶó°Õ ÆéŸÀ̵åÀÇ °Ç°­»óÀÇ ÀÌÁ¡¿¡ ´ëÇÑ °í°´ÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Äݶó°Õ ÆéŸÀ̵å À¯µµ ½Äǰ ¹× À½·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

À¯·´ÀÇ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå °³¿ä

À¯·´ÀÇ Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀº µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ¿µ±¹, ·¯½Ã¾Æ ¹× ±âŸ À¯·´À¸·Î ±¸ºÐµË´Ï´Ù. Ãß°¡ ¿µ¾ç¼Ò¸¦ ÇÔÀ¯ÇÑ ½Äǰ º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ö¿ä¿Í ³ëÈ­ ¹æÁö ¹Ì¿ë Á¦Ç°ÀÇ Àαâ´Â ÀÌ Áö¿ªÀÇ Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀ» Çü¼ºÇÏ´Â µÎ °¡Áö ÁÖ¿ä Æ®·»µåÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½Äǰ º¸ÃæÁ¦ »ê¾÷°ú °ü·ÃµÈ ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ ÁøÈ­ Ãß¼¼´Â ¼ÒºñÀÚÀÇ ±¸¸Å¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Äǰ º¸ÃæÁ¦ °ø±Þ¾÷üµéÀº ÀÌ Áö¿ª ¼ÒºñÀÚÀÇ ÃëÇâ¿¡ ¸Â°Ô Á¦Ç°À» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. Äݶó°Õ ÆéŸÀÌµå º¸ÃæÁ¦´Â °Ç°­ÇÑ Ã¼Áß °¨·®°ú »À °Ç°­ ÁõÁø¿¡ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ´Ü¹éÁú ÃÊÄݸ´ ÆÄ¿ì´õ, ¹Ù, ½Äǰ ¹× À½·á¿Í °°Àº °¡°ø½Äǰ ÇüÅ·Πº¸ÃæÁ¦¸¦ ¼·ÃëÇÏ´Â °æÇâÀÌ ³ô¾ÆÁö¸é¼­ À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀº Gelita AG, Protein S.A., Ewald-Gelatin GmbH, Rousselot SAS¿Í °°Àº ÀüÅë ÀÖ´Â ±â¾÷µéÀÇ Á¸Àç·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº ÀÚ»ç Á¦Ç°ÀÇ Áö¸®Àû ¹üÀ§¸¦ È®´ëÇϱâ À§ÇØ Á¦ÈÞ, ÆÄÆ®³Ê½Ê, ÇÕº´ µî ´Ù¾çÇÑ ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 10¿ù Rousselot SAS¿Í Giusto Faravelli´Â ÆÇ¸Å Á¦ÈÞ¸¦ ¸Î¾ú½À´Ï´Ù. À̹ø Á¦ÈÞ¸¦ ÅëÇØ Giusto Faravelli´Â ÀÌÅ»¸®¾Æ Àü¿ª¿¡¼­ RousselotÀÇ Á¦Ç°À» ÆÇ¸ÅÇÏ°Ô µË´Ï´Ù.

À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå 2030³â±îÁö ¸ÅÃâ ¹× ¿¹Ãø(±Ý¾×)

À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå ¼¼ºÐÈ­

À¯·´ÀÇ Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀº °ø±Þ¿ø, ÇüÅÂ, ¿ëµµ, ±¹°¡º°·Î ±¸ºÐµË´Ï´Ù.

°ø±Þ¿øÀ» ±âÁØÀ¸·Î À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀº ¼Ò, µÅÁö, °¡±Ý·ù, ÇØ¾ç ¹× ±âŸ·Î ¼¼ºÐÈ­µË´Ï´Ù. ¼Ò ºÎ¹®Àº 2023³â À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå¿¡¼­ °¡Àå Å« ½ÃÀå Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù.

ÇüÅ¿¡ µû¶ó ½ÃÀåÀº °ÇÁ¶¿Í ¾×ü·Î ±¸ºÐµÇ¸ç, 2023³â¿¡´Â °ÇÁ¶ ºÎ¹®ÀÌ ´õ Å« À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¿ëµµº°·Î À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀº À½·á ¹× ½Äǰ, ÀǾàǰ ¹× ¿µ¾ç º¸ÃæÁ¦, ÆÛ½º³ÎÄɾî, ±âŸ·Î ºÐ·ùµË´Ï´Ù. ÀǾàǰ ¹× °Ç°­ º¸Á¶ ½Äǰ ºÎ¹®Àº 2023³â À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±¹°¡º°·Î´Â À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀº µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ¿µ±¹, ·¯½Ã¾Æ, ±âŸ À¯·´À¸·Î ±¸ºÐµË´Ï´Ù. ±âŸ À¯·´Àº 2023³â À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå Á¡À¯À²À» µ¶Á¡Çß½À´Ï´Ù.

BioCell Technology LLC, Ewald-Gelatine GmbH, GELITA AG, Lapi Gelatine SpA, Rousselot BV, Tessenderlo Group NV, Weishardt Holding SA´Â ÀÌ Áö¿ªÀÇ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ŰÆ÷ÀÎÆ®

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¼öÁý
    • 1Â÷ ÀÎÅͺä
    • °¡¼³ Ã¥Á¤
    • °Å½Ã°æÁ¦ ¿äÀÎ ºÐ¼®
    • ±âÃÊ ¼öÄ¡ ÀÛ¼º
    • µ¥ÀÌÅÍ »ï°¢Ãø·®
    • ±¹°¡ ·¹º§ µ¥ÀÌÅÍ

Á¦4Àå À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå »óȲ

  • ½ÃÀå °³¿ä
  • Porter's Five Forces ºÐ¼®
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è
    • ´ëüǰÀÇ À§Çù
  • À¯·´ Àü¹®°¡ÀÇ °ßÇØ
  • »ýÅÂ°è ºÐ¼®
    • ¿øÀç·á
    • »ý»ê °øÁ¤
    • ÃÖÁ¾ ÀÌ¿ë »ê¾÷

Á¦5Àå À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Æø³ÐÀº ÀÀ¿ë ¹üÀ§
    • ½ÅÈï ½ÃÀåÀÇ ÁÖ¿ä ÁøÃâ ±â¾÷¿¡ ÀÇÇÑ Àü·«ÀûÀÎ ¹ßÀü¿¡ ´ëÇÑ ´ëó
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Äݶó°Õ ÆéŸÀÌµå ¼Òºñ¿¡ °üÇÑ ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ì·Á¿Í ¾ö°ÝÇÑ ±ÔÁ¦
  • ½ÃÀå ±âȸ
    • ÇØ¾ç À¯·¡ Äݶó°Õ ÆéŸÀÌµå ¼ö¿ä ±ÞÁõ
  • ÇâÈÄ µ¿Çâ
    • ÆÛ½º³ÎÄÉ¾î ¹× ¿µ¾ç È­ÀåǰÀÇ Äݶó°Õ ÆéŸÀÌµå »ç¿ë µ¿Çâ »ó½Â
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇ⠺м®

Á¦6Àå Äݶó°Õ ÆéŸÀ̵å À¯·´ ½ÃÀå ºÐ¼®

  • À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå °³¿ä

Á¦7Àå À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå ºÐ¼® - °ø±Þ¿øº°

  • °³¿ä
  • À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå : °ø±Þ¿øº°(2022³â, 2030³â)
  • ¼Ò
  • µÅÁö
  • °¡±Ý
  • ÇØ¾ç
  • ±âŸ

Á¦8Àå À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå ºÐ¼® : Çüź°

  • °³¿ä
  • À¯·´ÀÇ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå : Çüź°(2022³â, 2030³â)
  • °ÇÁ¶
  • ¾×»ó

Á¦9Àå À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå ºÐ¼® - ¿ëµµº°

  • °³¿ä
  • À¯·´ÀÇ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå : ¿ëµµº°(2022³â, 2030³â)
  • ½Äǰ¡¤À½·á
  • ÀǾàǰ°ú ´ºÆ®¶ó½´Æ¼ÄÃ
  • ÆÛ½º³ÎÄɾî
  • ±âŸ

Á¦10Àå À¯·´ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå : ±¹°¡º° ºÐ¼®

  • À¯·´
    • ±âŸ À¯·´

Á¦11Àå ±â¾÷ °³¿ä

  • GELITA AG
  • Rousselot BV
  • Tessenderlo Group NV
  • Ewald-Gelatine GmbH
  • BioCell Technology LLC
  • Lapi Gelatine SpA
  • Weishardt Holding SA

Á¦12Àå ºÎ·Ï

ksm 23.10.26

The Europe collagen peptides market is expected to grow from US$ 260.84 million in 2023 to US$ 379.61 million by 2030. It is estimated to grow at a CAGR of 5.5% from 2023 to 2030.

Wide Application Scope is Fuels Europe collagen peptides market.

Collagen peptide is a structural protein produced by hydrolysis of collagen found in connective tissue, skin, tendons, bones, cartilage, and other body parts. It supports tissues structurally and is involved in cellular functions such as tissue healing, immunological response, cellular communication, and cellular migration. Collagen is generally obtained from bovine connective tissues or marine sources. It has many applications across multiple end-use industries, including food & beverages, pharmaceuticals & nutraceuticals, and personal care. In the food & beverages industry, collagen peptide is used in yogurts, confectioneries, nutritional bars, ready-to-drink beverages, and others. Collagen peptide-induced foods and beverages enhance protein levels in the body; moreover, they help repair skin texture, improve bone and muscle health, and strengthen joints. Rising awareness regarding the health benefits of collagen peptides among customers is driving the demand for collagen peptide-induced foods and beverages.

Europe Collagen Peptides Market Overview

The collagen peptides market in Europe is segmented into Germany, France, Italy, the UK, Russia, and the Rest of Europe. Demand for food supplements with extra nutrients and popularity of antiaging beauty products are the two major trends shaping the collagen peptides market in the region. Such evolving lifestyle trends related to the food supplement industry are remarkably influencing the purchases of consumers. Moreover, food supplement providers are changing their offerings to meet consumer preferences in the region. Collagen peptides supplements help in healthy weight loss and improved bone health. Thus, the growing trend of taking supplements in the form of processed food, such as protein chocolate powder, bars, and beverages, is supporting the collagen peptides market growth in Europe.

The collagen peptides market is growing due to the presence of well-established players such as Gelita AG, Protein S.A., Ewald-Gelatin GmbH, and Rousselot SAS. These players are taking various initiatives such as collaborations, partnerships, and mergers to expand the geographical reach of their products. For instance, in October 2020, Rousselot SAS and Giusto Faravelli entered a distribution partnership. Through the partnership, Giusto Faravelli will distribute Rousselot's products across Italy.

Europe Collagen Peptides Market Revenue and Forecast to 2030 (US$ Million)

Europe Collagen Peptides Market Segmentation

The Europe collagen peptides market is segmented into source, form, application, and country.

Based on source, the Europe collagen peptides market is segmented into bovine, porcine, poultry, marine, and others. The bovine segment registered the largest Europe collagen peptides market share in 2023.

Based on form, the market is segmented into dry and liquid. The dry segment held a larger Europe collagen peptides market share in 2023.

Based on application, the Europe collagen peptide market is segmented into food & beverages, pharmaceuticals & nutraceuticals, personal care, and others. The pharmaceuticals & nutraceuticals segment held the largest Europe collagen peptide market share in 2023.

Based on country, the Europe collagen peptide market is segmented into Germany, France, Italy, the UK, Russia, and the Rest of Europe. The Rest of Europe dominated the Europe collagen peptide market share in 2023.

are BioCell Technology LLC; Ewald-Gelatine GmbH; GELITA AG; Lapi Gelatine SpA; Rousselot BV; Tessenderlo Group NV; and Weishardt Holding SA are the leading companies operating in the collagen peptide market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe collagen peptide market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe collagen peptide market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the collagen peptide market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation

2. Key Takeaways

3. Research Methodology

  • 3.1 Scope of the Study
  • 3.2 Research Methodology
    • 3.2.1 Data Collection:
    • 3.2.2 Primary Interviews:
    • 3.2.3 Hypothesis Formulation:
    • 3.2.4 Macro-economic Factor Analysis:
    • 3.2.5 Developing Base Number:
    • 3.2.6 Data Triangulation:
    • 3.2.7 Country Level Data:

4. Europe Collagen Peptides Market Landscape

  • 4.1 Market Overview
  • 4.2 Porter's Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Threat of New Entrants
    • 4.2.4 Competitive Rivalry
    • 4.2.5 Threat of Substitutes
  • 4.3 Europe Expert Opinion
  • 4.4 Ecosystem Analysis
    • 4.4.1 Raw Materials
    • 4.4.2 Production Process
    • 4.4.3 End-Use Industries

5. Europe Collagen Peptides Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Wide Application Scope
    • 5.1.2 Strategic Development Initiatives by Key Market Players
  • 5.2 Market Restraints
    • 5.2.1 Safety Concerns and Stringent Regulations Related to Consumption of Collagen Peptides
  • 5.3 Market Opportunities
    • 5.3.1 Surging Demand for Marine-Sourced Collagen Peptides
  • 5.4 Future Trends
    • 5.4.1 Escalating Trend of Using Collagen Peptides in Personal Care and Nutricosmetics
  • 5.5 Impact Analysis of Drivers and Restraints

6. Collagen Peptides - Europe Market Analysis

  • 6.1 Europe Collagen Peptides Market Overview
  • 6.2 Europe Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)

7. Europe Collagen Peptides Market Analysis - By Source

  • 7.1 Overview
  • 7.2 Europe Collagen Peptides Market, By Source (2022 and 2030)
  • 7.3 Bovine
    • 7.3.1 Overview
    • 7.3.2 Bovine: Europe Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Porcine
    • 7.4.1 Overview
    • 7.4.2 Porcine: Europe Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Poultry:
    • 7.5.1 Overview
    • 7.5.2 Poultry: Europe Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Marine:
    • 7.6.1 Overview
    • 7.6.2 Marine: Europe Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Europe Collagen Peptides Market- Revenue and Forecast to 2030 (US$ Million)

8. Europe Collagen Peptides Market Analysis - By Form

  • 8.1 Overview
  • 8.2 Europe Collagen Peptides Market, By Form (2022 and 2030)
  • 8.3 Dry
    • 8.3.1 Overview
    • 8.3.2 Dry: Europe Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Liquid
    • 8.4.1 Overview
    • 8.4.2 Liquid: Europe Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Collagen Peptides Market Analysis - By Application

  • 9.1 Overview
  • 9.2 Europe Collagen Peptides Market, By Application (2022 and 2030)
  • 9.3 Food and Beverages
    • 9.3.1 Overview
    • 9.3.2 Food and Beverages: Europe Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Pharmaceuticals and Nutraceuticals
    • 9.4.1 Overview
    • 9.4.2 Pharmaceuticals and Nutraceuticals: Europe Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Personal Care
    • 9.5.1 Overview
    • 9.5.2 Personal Care: Europe Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Europe Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Collagen Peptides Market - Country Analysis

  • 10.1 Overview
  • 10.2 Europe: Collagen Peptides Market
    • 10.2.1 Europe: Collagen Peptides Market, by Key Country
      • 10.2.1.1 Germany: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.1.1.1 Germany: Collagen Peptides Market, By Source
        • 10.2.1.1.2 Germany: Collagen Peptides Market, By Form
        • 10.2.1.1.3 Germany: Collagen Peptides Market, by Application
      • 10.2.1.2 UK: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.1.2.1 UK: Collagen Peptides Market, By Source
        • 10.2.1.2.2 UK: Collagen Peptides Market, By Form
        • 10.2.1.2.3 UK: Collagen Peptides Market, by Application
      • 10.2.1.3 France: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.1.3.1 France: Collagen Peptides Market, By Source
        • 10.2.1.3.2 France: Collagen Peptides Market, By Form
        • 10.2.1.3.3 France: Collagen Peptides Market, by Application
      • 10.2.1.4 Italy: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.1.4.1 Italy: Collagen Peptides Market, By Source
        • 10.2.1.4.2 Italy: Collagen Peptides Market, By Form
        • 10.2.1.4.3 Italy: Collagen Peptides Market, by Application
      • 10.2.1.5 Russia: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.1.5.1 Russia: Collagen Peptides Market, By Source
        • 10.2.1.5.2 Russia: Collagen Peptides Market, By Form
        • 10.2.1.5.3 Russia: Collagen Peptides Market, by Application
      • 10.2.1.6 Rest of Europe: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.1.6.1 Rest of Europe: Collagen Peptides Market, By Source
        • 10.2.1.6.2 Rest of Europe: Collagen Peptides Market, By Form
        • 10.2.1.6.3 Rest of Europe: Collagen Peptides Market, by Application

11. Company Profiles

  • 11.1 GELITA AG
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Rousselot BV
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Tessenderlo Group NV
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Ewald-Gelatine GmbH
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 BioCell Technology LLC
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Lapi Gelatine SpA
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Weishardt Holding SA
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Word Index
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦